Prognostic value of high-sensitivity cardiac troponin I in patients with non-ischaemic heart failure: insights from China.

ABSTRACT:

Aims

Evidence of the prognostic value of high-sensitivity troponin in patients with non-ischaemic heart failure (NIHF) is scarce. This study aimed to assess the predictive value of high-sensitivity cardiac troponin I (hs-cTnI) in NIHF patients.

Methods

Hs-cTnI was measured at baseline in 650 NIHF patients admitted to the Heart Failure Center. The prognostic value of hs-cTnI was assessed based on a well-established model (including age, sex, New York Heart Association class, left ventricular ejection fraction, haemoglobin, sodium, estimated glomerular filtration rate, diabetes mellitus, treatment with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, treatment with β-blockers, and NT-proBNP).

Results

During a median follow-up of 1036 days, 1

SUBMITTER: Tian P 

PROVIDER: S-EPMC9715791 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature